HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Nakamura Selected Research

Adrenocortical Adenoma (Disease, Conn's)

1/2022Bilateral adrenal uptake of 123I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics.
11/2020Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; ∼An association among morphometry, genotype and cellular senescence∼.
9/2020Adrenal Corticomedullary Mixed Tumor Associated With the FGFR4-G388R Variant.
6/2020The Effect of Extracellular Calcium Metabolism on Aldosterone Biosynthesis in Physiological and Pathological Status.
2/2020Unique Sex Steroid Profiles in Estrogen-Producing Adrenocortical Adenoma Associated With Bilateral Hyperaldosteronism.
1/201918-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
1/2018Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.
11/2016Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance.
1/2016Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative real-time polymerase chain reaction studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Nakamura Research Topics

Disease

89Neoplasms (Cancer)
10/2022 - 10/2003
45Adenoma (Adenomas)
02/2022 - 04/2011
35Hyperaldosteronism (Conn Syndrome)
01/2022 - 08/2006
22Melanoma (Melanoma, Malignant)
10/2022 - 04/2009
21Carcinoma (Carcinomatosis)
06/2022 - 01/2005
17Myocardial Infarction
04/2015 - 02/2002
16Neoplasm Metastasis (Metastasis)
01/2022 - 07/2009
14Breast Neoplasms (Breast Cancer)
01/2022 - 12/2005
10Prostatic Neoplasms (Prostate Cancer)
11/2021 - 03/2005
10Hyperplasia
01/2021 - 01/2003
9Adrenocortical Adenoma (Disease, Conn's)
01/2022 - 01/2016
8Adrenocortical Carcinoma
01/2022 - 02/2011
7Skin Neoplasms (Skin Cancer)
10/2022 - 01/2011
7Fibrosis (Cirrhosis)
08/2022 - 01/2003
7Esophageal Squamous Cell Carcinoma
06/2022 - 10/2007
7Cushing Syndrome
01/2022 - 01/2011
6Inflammation (Inflammations)
01/2021 - 11/2012
6Hypertension (High Blood Pressure)
01/2020 - 01/2012
5Infarction (Infarctions)
11/2020 - 06/2004
5Heart Failure
10/2018 - 11/2008
5Atherosclerosis
01/2014 - 10/2003
4Lymphatic Metastasis
09/2021 - 10/2013
4Cardiovascular Diseases (Cardiovascular Disease)
06/2020 - 01/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2020 - 02/2009
4Adenocarcinoma
01/2017 - 08/2011
4Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2016 - 07/2007
4Noninfiltrating Intraductal Carcinoma (DCIS)
10/2015 - 08/2012
3Necrosis
10/2022 - 07/2008
3Extramammary Paget Disease (Paget Disease, Extramammary)
09/2021 - 11/2015
3Pheochromocytoma
09/2020 - 12/2018
3Vitiligo
06/2020 - 01/2017
3Interstitial Lung Diseases (Interstitial Lung Disease)
10/2018 - 07/2014
3Carcinogenesis
06/2016 - 01/2013
3Ischemia
01/2015 - 06/2004
3Hemangiosarcoma (Angiosarcoma)
10/2014 - 01/2011
3Pituitary Neoplasms (Pituitary Adenoma)
11/2013 - 07/2012
3Hypertrophy
01/2012 - 01/2002

Drug/Important Bio-Agent (IBA)

49AldosteroneIBA
02/2022 - 08/2006
32EnzymesIBA
01/2022 - 10/2003
20Hydrocortisone (Cortisol)FDA LinkGeneric
02/2022 - 01/2011
20Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2005
19Estrogens (Estrogen)FDA Link
09/2021 - 01/2003
18SteroidsIBA
01/2022 - 01/2003
16Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2022 - 02/2011
16AndrogensIBA
11/2021 - 03/2005
16Biological ProductsIBA
01/2021 - 04/2005
13Messenger RNA (mRNA)IBA
01/2022 - 03/2002
10Oxidoreductases (Dehydrogenase)IBA
01/2016 - 12/2005
9Estrogen ReceptorsIBA
01/2021 - 11/2012
9Androgen Receptors (Androgen Receptor)IBA
01/2021 - 05/2006
9Hormones (Hormone)IBA
01/2021 - 01/2003
9LipidsIBA
11/2020 - 05/2009
8NivolumabIBA
08/2021 - 06/2016
8Transcription Factors (Transcription Factor)IBA
07/2021 - 04/2005
8Monoclonal AntibodiesIBA
06/2016 - 01/2005
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2004
6Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2022 - 07/2014
6Aromatase (CYP19)IBA
09/2021 - 12/2005
6Progesterone Receptors (Progesterone Receptor)IBA
01/2018 - 05/2013
5Immune Checkpoint InhibitorsIBA
11/2021 - 09/2016
5LigandsIBA
11/2021 - 05/2009
5Adrenocorticotropic Hormone (ACTH)FDA Link
11/2020 - 01/2011
5Indocyanine Green (Cardio-Green)FDA LinkGeneric
08/2018 - 01/2011
4CholesterolIBA
02/2022 - 01/2014
4AntibodiesIBA
11/2021 - 09/2016
4Steryl-Sulfatase (Steroid Sulfatase)IBA
01/2021 - 12/2005
4Cisplatin (Platino)FDA LinkGeneric
09/2020 - 02/2009
4AntigensIBA
09/2019 - 04/2009
418-oxocortisolIBA
01/2019 - 08/2011
4Protein Isoforms (Isoforms)IBA
01/2018 - 02/2014
4Estrogen Receptor betaIBA
01/2017 - 04/2004
4Aromatase InhibitorsIBA
10/2015 - 04/2007
4Angiotensin IIIBA
12/2014 - 01/2003
3Testosterone (Sustanon)FDA Link
09/2021 - 04/2014
3Estradiol (Delestrogen)FDA LinkGeneric
09/2021 - 06/2006
3estrone sulfotransferaseIBA
01/2021 - 06/2006
3Dehydroepiandrosterone (DHEA)IBA
11/2020 - 04/2014
3pembrolizumabIBA
09/2020 - 10/2018
3CalciumIBA
06/2020 - 11/2004
3TolvaptanFDA Link
10/2018 - 11/2012
3DiureticsIBA
10/2018 - 11/2012
3ProgesteroneFDA LinkGeneric
01/2018 - 12/2005
3Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
01/2017 - 01/2010
3Carbon DioxideIBA
06/2015 - 01/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 06/2005
3Coloring Agents (Dyes)IBA
06/2013 - 04/2012
3Pharmaceutical PreparationsIBA
01/2013 - 06/2004
3Glucose (Dextrose)FDA LinkGeneric
10/2012 - 01/2011
3Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 09/2006

Therapy/Procedure

30Therapeutics
10/2022 - 03/2004
9Drug Therapy (Chemotherapy)
09/2020 - 07/2009
8Lymph Node Excision (Lymph Node Dissection)
10/2022 - 11/2011
6Adrenalectomy
02/2022 - 07/2011
6Aftercare (After-Treatment)
05/2021 - 08/2009
4Lasers (Laser)
01/2022 - 12/2005
4Immunotherapy
11/2021 - 04/2009
4Ligation
01/2012 - 03/2002
3Neoadjuvant Therapy
06/2022 - 10/2005
3Transplantation
01/2021 - 06/2005
3Surgical Amputation (Amputations)
05/2020 - 09/2015